Efficacy of Oral Alendronate in Children With Osteogenesis Imperfecta
暂无分享,去创建一个
[1] R. Engelbert,et al. Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study , 2004, The Lancet.
[2] F. Glorieux,et al. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. , 2003, Pediatrics.
[3] A. Oberbauer,et al. Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. , 2003, Bone.
[4] A. Boskey,et al. Alendronate Treatment for Infants with Osteogenesis Imperfecta: Demonstration of Efficacy in a Mouse Model , 2002, Pediatric Research.
[5] F. Glorieux,et al. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. , 2002, The Journal of clinical investigation.
[6] L. Root,et al. A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta , 2001, Calcified Tissue International.
[7] I Larzillière,et al. [Esophagitis associated with the use of alendronate]. , 1999, Gastroenterologie clinique et biologique.
[8] F. Glorieux,et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. , 1998, The New England journal of medicine.
[9] S. Söderhäll,et al. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta , 1998, Acta paediatrica.
[10] G. Massa,et al. Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate) , 1997, European Journal of Pediatrics.
[11] R. Ball,et al. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate , 1997, Archives of disease in childhood.
[12] J. Mucklow,et al. Studies of the oral bioavailability of alendronate , 1995, Clinical pharmacology and therapeutics.
[13] B. Maldague,et al. Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta , 2004, Skeletal Radiology.
[14] I. Fujiwara,et al. Intravenous pamidronate treatment in osteogenesis imperfecta. , 1998, European journal of pediatrics.
[15] J. Huaux,et al. Is APD a promising drug in the treatment of severe osteogenesis imperfecta? , 1988, Journal of pediatric orthopedics.